Tenpoint Therapeutics has appointed Stephen Lane as its new chief medical officer, effective immediately. Lane brings extensive experience to the role, having previously served as chief medical officer and head of medical safety at Alcon.
In addition to his new position at Tenpoint Therapeutics, Lane holds the role of executive chair at the Holland Foundation for Sight Restoration, further solidifying his expertise in medical leadership and innovation.
Leadership Background and Career Highlights
Before joining Tenpoint Therapeutics, Lane played a pivotal role at Alcon, where he was responsible for overseeing medical strategy and safety protocols. His career spans decades of leadership in the medical and pharmaceutical sectors, making him a valuable addition to the company’s executive team.
Company Impact and Strategic Direction
The appointment of Stephen Lane reflects Tenpoint Therapeutics’ commitment to advancing its medical and therapeutic initiatives. His leadership is expected to drive innovation and strengthen the company’s position in the healthcare industry.
For more details on this leadership change and other industry updates, visit STAT+.
Related articles
FDA Drug Center Acting Director Tracy Beth Høeg Departs Amid Leadership Changes
WASHINGTON — The acting director of the Food and Drug Administration’s drug center, Tracy Beth Høeg, is leaving the agency, according to three sources...
STAT+ Roundup: New Hires and Promotions in Biotech and Pharma
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others....
U.S. Pressures Germany to Increase Payments for Prescription Drugs Amid Trade Tensions
WASHINGTON — Over a recent breakfast, U.S. officials had a message for the German ambassador: pay more for pharmaceuticals. The meeting, between U.S....
Dr. Makary's Exit and the Future of Cassidy's Senate Seat: Key Health Policy Shifts
This week’s episode of “The Readout LOUD” is all about health politics. We bring on FDA reporter Lizzy Lawrence to discuss Makary’s departure — why he...
Ballmaxxing: The Dangerous Testicle Enhancement Trend You Need to Know About
Experts say that “Ballmaxxing” may lead to permanent damage. Image Credit: Heathline/Paloma Rincon Studio/GettyImages Ballmaxxing is the latest social...
Who Will Lead the FDA Next? The Search for a New Commissioner Heats Up
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to...
BeOne Secures FDA Approval for Novel Lymphoma Cell Therapy, Advancing Autoimmune Treatment Pipeline
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Biotech’s cell therapy boo...
Why Major Digital Health Companies Are Absent from Medicare’s Chronic Care Pilot Program
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it deli...